Optimal blood pressure levels in different phases of peripheral thrombolysis period in acute ischemic stroke

医学 内科学 心脏病学 溶栓 冲程(发动机) 缺血性中风 血压 麻醉 急性中风 外围设备 组织纤溶酶原激活剂
作者
Minqiang He,Hongrui Wang,Yi Tang,Bing Cui,Bin Xu,Ying Sun,Guanghui Zhang,Xu He,Xiaoqin Niu,Bei Wang,Biao Xu,Zaipo Li,Rutai Hui,Yibo Wang
出处
期刊:Journal of Hypertension [Ovid Technologies (Wolters Kluwer)]
卷期号:39 (7): 1453-1461 被引量:4
标识
DOI:10.1097/hjh.0000000000002812
摘要

Dramatic changes of blood pressure (BP) were observed in the peripheral thrombolysis period, however, there is no consensus about BP control targets in the different phases.We retrospectively studied a consecutive sample of 510 patients treated with intravenous thrombolysis and followed-up for 3 months. The peripheral thrombolysis period was divided into these phases: Phase 1 (from onset to thrombolysis), Phase 2 (thrombolysis), Phase 3 (from thrombolysis to 24 h after thrombolysis), and Phase 4 (from 24 h to 7 days after thrombolysis). Patients were divided into quintiles according to mean blood pressure in these phases, respectively. Neurological improvement was evaluated using the modified Rankin Scale score at 3-month after thrombolysis.Lower risk of intracerebral hemorrhage within 7 days was found in lower quintiles of SBP (OR = 0.100, 95% CI 0.011-0.887, P = 0.039 in Phase 1 quintile Q1, OR = 0.110, 95% CI 0.012-0.974, P = 0.047 in Phase 2-3 quintile Q1, and OR, 0.175, 95% CI, 0.035-0.872; P = 0.033 in Phase 4 quintile Q2, respectively). Better neurological improvement was found in SBP quintiles: Q2-Q4 (127.3-155.7 mmHg) in Phase 4 (OR = 3.095, 95% CI 1.524-6.286, P = 0.002 for Q2; OR = 2.697, 95% CI 1.354-5.370, P = 0.005 for Q3; and OR = 2.491, 95% CI 1.263-4.913, P = 0.008 for Q4, respectively). Our results also showed higher average real variability of SBP was negatively associated with better neurological outcome in Phase 1 and Phase 2-3.Maintaining SBP levels (≤148 mmHg) from admission to the first 24 h after thrombolysis, then keeping SBP levels (127-138 mmHg) would be beneficial.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Sigyn完成签到,获得积分10
刚刚
顺利琦发布了新的文献求助10
刚刚
刚刚
自由完成签到,获得积分20
1秒前
Volta_zz完成签到,获得积分10
1秒前
1秒前
欣欣子完成签到,获得积分10
2秒前
3秒前
111完成签到 ,获得积分10
3秒前
3秒前
柔弱煎饼发布了新的文献求助30
4秒前
4秒前
曹梦梦完成签到,获得积分10
4秒前
4秒前
风趣霆完成签到,获得积分10
5秒前
5秒前
5秒前
小二郎应助Sigyn采纳,获得10
5秒前
科研通AI5应助不对也没错采纳,获得10
5秒前
lyn完成签到,获得积分20
5秒前
6秒前
隐形觅翠完成签到,获得积分10
6秒前
刘鹏宇发布了新的文献求助10
6秒前
lizh187完成签到 ,获得积分10
6秒前
北城完成签到,获得积分10
6秒前
自由发布了新的文献求助10
7秒前
7秒前
小豆芽儿发布了新的文献求助10
7秒前
WNL发布了新的文献求助10
8秒前
Ngu完成签到,获得积分10
8秒前
科研通AI5应助冷艳后妈采纳,获得10
8秒前
陶1122发布了新的文献求助10
8秒前
万能图书馆应助乐观期待采纳,获得30
8秒前
krystal完成签到,获得积分10
8秒前
学术大小拿完成签到,获得积分10
9秒前
迪迦完成签到,获得积分10
9秒前
10秒前
乖乖发布了新的文献求助10
10秒前
10秒前
song24517发布了新的文献求助20
10秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527469
求助须知:如何正确求助?哪些是违规求助? 3107497
关于积分的说明 9285892
捐赠科研通 2805298
什么是DOI,文献DOI怎么找? 1539865
邀请新用户注册赠送积分活动 716714
科研通“疑难数据库(出版商)”最低求助积分说明 709678